Avantor, Inc. (NYSE:AVTR) Shares Purchased by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB raised its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 40.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 61,826 shares of the company's stock after purchasing an additional 17,826 shares during the quarter. Rhenman & Partners Asset Management AB's holdings in Avantor were worth $1,303,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in AVTR. Cerity Partners LLC grew its position in shares of Avantor by 122.6% during the 3rd quarter. Cerity Partners LLC now owns 30,538 shares of the company's stock worth $790,000 after buying an additional 16,818 shares in the last quarter. Bank of Montreal Can purchased a new stake in Avantor during the third quarter worth $2,575,000. Captrust Financial Advisors increased its holdings in shares of Avantor by 26.4% in the 3rd quarter. Captrust Financial Advisors now owns 17,852 shares of the company's stock valued at $462,000 after acquiring an additional 3,733 shares during the period. Investment Management Corp of Ontario raised its position in shares of Avantor by 49.7% in the 3rd quarter. Investment Management Corp of Ontario now owns 22,585 shares of the company's stock worth $584,000 after acquiring an additional 7,500 shares in the last quarter. Finally, Royal London Asset Management Ltd. lifted its stake in shares of Avantor by 1.8% during the 3rd quarter. Royal London Asset Management Ltd. now owns 254,888 shares of the company's stock worth $6,594,000 after purchasing an additional 4,580 shares during the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

AVTR has been the subject of several analyst reports. Raymond James reissued an "outperform" rating and set a $24.00 price target (down from $26.00) on shares of Avantor in a research report on Monday, February 10th. Stifel Nicolaus lowered their target price on shares of Avantor from $28.00 to $26.00 and set a "buy" rating for the company in a research note on Monday, February 10th. Royal Bank of Canada reduced their price target on Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a research report on Monday, February 10th. Citigroup decreased their price objective on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a report on Tuesday, March 4th. Finally, Barclays dropped their target price on Avantor from $23.00 to $18.00 and set an "overweight" rating on the stock in a research note on Thursday. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $25.08.

Avantor Stock Performance

NYSE AVTR traded down $1.19 on Thursday, hitting $14.70. 4,679,046 shares of the company's stock traded hands, compared to its average volume of 6,738,124. The firm has a market capitalization of $10.01 billion, a PE ratio of 14.13, a P/E/G ratio of 1.55 and a beta of 1.24. Avantor, Inc. has a 1-year low of $13.80 and a 1-year high of $28.00. The firm's 50-day moving average price is $17.08 and its two-hundred day moving average price is $20.63. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54.

Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period last year, the business earned $0.22 EPS. As a group, analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Insider Buying and Selling at Avantor

In other news, CAO Steven W. Eck sold 4,907 shares of the firm's stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the sale, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. This trade represents a 10.78 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares in the company, valued at $1,531,753.87. This represents a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.